# Retrospective Multi-cohort Study of Frontline Afatinib Followed by 2nd Line Therapy Including Osimertinib, Chemotherapy or Other Therapy

> **NCT04930133** · — · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 737 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Gilotrif

## Key facts

- **NCT ID:** NCT04930133
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-24
- **Primary completion:** 2020-12-17
- **Final completion:** 2021-09-30
- **Target enrollment:** 737 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930133, "Retrospective Multi-cohort Study of Frontline Afatinib Followed by 2nd Line Therapy Including Osimertinib, Chemotherapy or Other Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04930133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*